In addition, the increased CRT exposure and enhanced HMGB1 release were also both confirmed by CRT staining of tumor tissue sections and western blot analysis of CRT and HMGB1 expressions (Figure 4e,g). The gene discussed is HMGB1; the disease is neoplasm.